Tamer T. Onder

Sariyer, Turkey

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

Single-gene knockout of RNLS or HIVEP2 are insufficient to protect β-cell spheroids from allo- and xeno-rejection.

Single-gene knockout of RNLS or HIVEP2 are insufficient to protect β-cell spheroids from allo- and xeno-rejection.

Journal: Frontiers in immunology

Published: December 03, 2025

Menin-driven mTOR signaling sustains taxane resistance in CRPC and reveals a targetable vulnerability for combination therapy.

Menin-driven mTOR signaling sustains taxane resistance in CRPC and reveals a targetable vulnerability for combination therapy.

Journal: Cell communication and signaling : CCS

Published: July 15, 2025

Generation of Functional Endodermal Hepatic Organoids.

Generation of Functional Endodermal Hepatic Organoids.

Journal: Journal of visualized experiments : JoVE

Published: May 19, 2025

The histone-methyltransferase DOT1L cooperates with LSD1 to control cell division in blast-phase MPN.

The histone-methyltransferase DOT1L cooperates with LSD1 to control cell division in blast-phase MPN.

Journal: Leukemia

Published: January 06, 2025

Chromatin-focused genetic and chemical screens identify BRPF1 as a targetable vulnerability in Taxol-resistant triple-negative breast cancer.

Chromatin-focused genetic and chemical screens identify BRPF1 as a targetable vulnerability in Taxol-resistant triple-negative breast cancer.

Journal: Experimental & molecular medicine

Published: April 18, 2024

Identification of selective SWI/SNF dependencies in enzalutamide-resistant prostate cancer.

Identification of selective SWI/SNF dependencies in enzalutamide-resistant prostate cancer.

Journal: Communications biology

Published: February 28, 2024

Relationship between HER2-low status and efficacy of CDK4/6 inhibitors in advanced breast cancer: a real-world study.

Relationship between HER2-low status and efficacy of CDK4/6 inhibitors in advanced breast cancer: a real-world study.

Journal: International journal of clinical oncology

Published: February 12, 2024

A chromatin-focused CRISPR screen identifies USP22 as a barrier to somatic cell reprogramming.

A chromatin-focused CRISPR screen identifies USP22 as a barrier to somatic cell reprogramming.

Journal: Communications biology

Published: January 29, 2024

Epigenetic-focused CRISPR/Cas9 screen identifies (absent, small, or homeotic)2-like protein (ASH2L) as a regulator of glioblastoma cell survival.

Epigenetic-focused CRISPR/Cas9 screen identifies (absent, small, or homeotic)2-like protein (ASH2L) as a regulator of glioblastoma cell survival.

Journal: Cell communication and signaling : CCS

Published: May 02, 2023

Perspectives on current models of Friedreich's ataxia.

Perspectives on current models of Friedreich's ataxia.

Journal: Frontiers in cell and developmental biology

Published: May 31, 2022

BRD9-containing non-canonical BAF complex maintains somatic cell transcriptome and acts as a barrier to human reprogramming.

BRD9-containing non-canonical BAF complex maintains somatic cell transcriptome and acts as a barrier to human reprogramming.

Journal: Stem cell reports

Published: March 29, 2022

EPIKOL, a chromatin-focused CRISPR/Cas9-based screening platform, to identify cancer-specific epigenetic vulnerabilities.

EPIKOL, a chromatin-focused CRISPR/Cas9-based screening platform, to identify cancer-specific epigenetic vulnerabilities.

Journal: Cell death & disease

Published: March 22, 2022

Showing 1-12 of 34

Last Updated: 09/26/2026